Teva's Indictment Came After Talks Faltered With Justice Department - WSJ
Teva, distributors sidestep Ohio opioid trial with last-minute deal: WSJ | Fierce Pharma
Now Comes the Hard Part at Teva - WSJ
Teva May Need to Pay Up to Lure a CEO Able to Reverse Its Fortunes - WSJ
Israeli drug manufacturer Teva at center of anti-trust lawsuit brought by 44 states - Jewish Telegraphic Agency
Teva Pharmaceutical's Sales Slump 18% - WSJ
P&G to name David Taylor CEO: WSJ | Reuters.com
Israel stocks at record; banks, Teva in focus - MarketWatch
Teva Faces U.S. Criminal Probe on Opioid-Related Distribution, Report Says | Ctech
Teva in talks to buy Allergan big generic-drug unit: WSJ | Reuters.com
利回りのない世界、希望的観測抱く投資家 | WSJ PickUp | ダイヤモンド・オンライン
Teva Part of Consortium Looking to Participate in Purdue Pharma's Bankruptcy, Report Says | Ctech
Mylan's Leverage to Resist Teva Deal Reveals Shift in Rules - WSJ
FDA Rejects Teva's Application For Huntington's Drug - WSJ
Teva Nears Deal For Allergan's Generic Drugs Unit | Mint
Teva Pharmaceutical Is in Recovery - WSJ
Teva found liable for fueling opioid addiction in New York | Mint
Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says | Ctech
Oklahoma, USA: Opioid-Krise: Ratiopharm-Mutter Teva zahlt 85 Millionen US-Dollar
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Teva Settles Foreign Corruption Probe for $519 Million - WSJ
Teva Gives Downbeat Earnings Forecast - WSJ
GitHub - CharlesBean/WSJTeva: TEvA Applied to WSJ
Teva shares approach 20-year low amid Moody's warning and other woes | Fierce Pharma
Teva in talks to buy Allergan big generic-drug unit: WSJ | Reuters
Teva Found Liable for Fueling Opioid Addiction in New York - WSJ
Opioid Risk Smothers Drug Stocks - WSJ
Johnson & Johnson, Teva, others face federal criminal probe into opioid sales: WSJ | Fierce Pharma
Teva back on the hook for $235M to GSK for heart drug infringement | Fierce Pharma
